Aalok Shanghvi completed his graduation in Cellular and Molecular Biology from the University of Michigan, US.

Sun Pharmaceutical Industries has elevated Aalok Shanghvi, son of MD Dilip Shanghvi, as its new Chief Operating Officer.

Sun Pharma, India’s pharmaceutical giant, has elevated Aalok Shanghvi, the son of Dilip Shanghvi, chairman and managing ...

Sun Pharma appoints Aalok Shanghvi as COO, overseeing global operations and R&D, with expertise in emerging markets.

Sun Pharma has promoted Aalok Shanghvi to Chief Operating Officer. Previously a Whole-time Director, Shanghvi has been with the company since 2006. Known for his diverse role experience, he has ...

The next generation has been entrusted with more responsibility at the family-run Sun Pharma, India’s largest drug maker, and ...

Emerging markets business contributes about 18% to Sun Pharma’s global revenues. Subsequently, he took additional charge of global generic R&D, global business development (generics), operations and ...

Shanghvi, who joined the company in 2006, currently designated as Whole-time Director and Executive Vice-President, Emerging Markets, Global Generic R&D, Global Business Development (Generics), ...